Maintenance Poly (ADP-ribose) Polymerase Inhibitor Therapy for Ovarian Cancer: Precision Oncology or One Size Fits All?
Author:
Affiliation:
1. Andrew Berchuck, Angeles Alvarez Secord, Haley A. Moss, and Laura J. Havrilesky, Duke University Medical Center, Durham, NC
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2017.74.5752
Reference11 articles.
1. Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation
2. Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
3. Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
4. Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
5. Niraparib in Recurrent Ovarian Cancer
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Lessons learned from postmarketing withdrawals of expedited approvals for oncology drug indications;The Lancet Oncology;2024-03
2. Ex vivo chemosensitivity assay using primary ovarian cancer organoids for predicting clinical response and screening effective drugs;Human Cell;2022-12-07
3. Understanding the needs and perspectives of ovarian cancer patients when considering PARP inhibitor maintenance therapy: Findings from two online community events;Gynecologic Oncology Reports;2022-10
4. Endometriosis-associated epithelial ovarian cancer is a more complicated disease than we suspected before;Taiwanese Journal of Obstetrics and Gynecology;2021-11
5. Clinical benefit of systemic therapies for recurrent ovarian cancer—ESMO-MCBS scores;ESMO Open;2021-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3